Conversely, the Burkitt lymphoma cell line-specific SNP, APC, demonstrated a 20-fold or greater suppression following xMD (lymphoma/lung carcinoma cell line—46.6% vs. 2.3; lymphoma/melanoma cell line—52.3% vs. undetectable). This evidence concerns the gene APC and lung carcinoma.